Aytu Biopharma (AYTU) Gross Profit (2014 - 2026)
Aytu Biopharma's Gross Profit came in at $10.41 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 1.5% from $10.25 million a year earlier and up 37.0% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Gross Profit (2014 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Gross Profit was $36.82 million, down 19.7% from FY2025.
- Gross Profit has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 4.7% (FY2021 to FY2026).
- Going back by fiscal year, Gross Profit was $45.83 million in FY2025 (-6.6%), $49.05 million in FY2024 (-26.4%), $66.63 million in FY2023 (+27.4%) and $52.28 million in FY2022 (+79.1%).
- The fiscal Q4 2026 figure represents the highest quarterly Gross Profit since fiscal Q3 2025.
- Year-over-year, Gross Profit increased in two of the last eight quarters, with an average decline of 11.4%.
- The fastest year-over-year change in Gross Profit over five years came in fiscal Q1 2023 (growth of 44.8%), and the weakest in fiscal Q3 2026 (a decline of 40.7%).
- Business Quant data shows AYTU's Gross Profit at $7.6 million (Q3 2026), $9.62 million (Q2 2026) and $9.19 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.41 Mn |
| Mar 31, 2026 | 7.60 Mn |
| Dec 31, 2025 | 9.62 Mn |
| Sep 30, 2025 | 9.19 Mn |
| Jun 30, 2025 | 10.25 Mn |
| Mar 31, 2025 | 12.81 Mn |
| Dec 31, 2024 | 10.79 Mn |
| Sep 30, 2024 | 11.99 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Mar 31, 2024 | 10.36 Mn |
| Dec 31, 2023 | 14.60 Mn |
| Sep 30, 2023 | 13.04 Mn |
| Jun 30, 2023 | 18.56 Mn |
| Mar 31, 2023 | 12.74 Mn |
| Dec 31, 2022 | 17.29 Mn |
| Sep 30, 2022 | 18.03 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Mar 31, 2022 | 12.69 Mn |
| Dec 31, 2021 | 12.30 Mn |
| Sep 30, 2021 | 12.46 Mn |
API Access
Aytu Biopharma Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();